Immunotherapy Potentiates the Effect of Chemotherapy in Metastatic Melanoma—A Retrospective Study

Melanoma survival increased with targeted- and immunotherapy agents, yet most patients ultimately progress and require salvage therapy. In our experience, some progressive disease patients on immune-checkpoint inhibitors (ICIs) demonstrate deep and sustained responses to chemotherapy. We hypothesize...

Full description

Bibliographic Details

Published in:	Frontiers in Oncology
Main Authors:	Reut Hadash-Bengad, Emma Hajaj, Shiri Klein, Sharon Merims, Stephen Frank, Galit Eisenberg, Alexander Yakobson, Marina Orevi, Nadia Caplan, Tamar Peretz, Michal Lotem, Jonatan E. Cohen
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2020-02-01
Subjects:	immune checkpoint inhibitors malignant melanoma chemotherapy salvage therapy immune-monitoring
Online Access:	https://www.frontiersin.org/article/10.3389/fonc.2020.00070/full